Ypsomed Holding AG - Company Profile
Powered by 
All the sales intelligence you need on Ypsomed Holding AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Ypsomed Holding AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Ypsomed Holding AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Ypsomed Holding AG (Ypsomed) is a medical device company. It designs, develops, and manufactures injection and infusion systems for self-medication and offers related services. The company's products find application in the treatment of diabetes, infertility, growth disorders and various other clinical indications. Ypsomed's product portfolio includes autoinjectors, dual chamber pens, and pen injectors. The company also provides services ranging from design and development projects, flexible prototyping, human factors engineering, monitoring services, therapy management and IP landscape management to manufacturing and assembly infrastructure and registration support. Ypsomed offers solutions to physicians and pharmaceutical and biotechnology companies. The company operates in Europe and North America, among other regions.. Ypsomed is headquartered in Burgdorf, Switzerland.
Headquarters
Switzerland
Address
Brunnmattstrasse 6, Burgdorf, 3401
Website
www.ypsomed.com
Telephone
41 34 4244111
No of Employees
2,099
Industry
Medical Equipment
Ticker Symbol & Exchange
YPSN (SWF)
Revenue (2025)
$880.2M
-2.4%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
153.6%
(2025 vs 2024)
Market Cap*
$5.6B
Net Profit Margin (2025)
XYZ
159.7%
(2025 vs 2024)
* As of and is in US$
Ypsomed Holding AG premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Delivery Systems: | Contract Manufacturing | Penfine |
| Autoinjectors | Design and Development Services | Universal Click |
| Pen Injectors | Prototyping | Humatro-Pen |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In September, the company signed a partnership with Ci Design to launch its first US-based advanced manufacturing facility in Holly Springs, North Carolina, the US. |
| 2026 | Contracts/Agreements | In June 2026, the company entered into an agreement with Stevanato Group for the integration of Stevanato Group’s prefilled syringes into Ypsomed’s YpsoMate autoinjector platform. |
| 2026 | Corporate Changes/Expansions | In April, the company opened its new tool manufacturing facility in Solothurn, Switzerland. |
Competitor Comparison
| Key Parameters | Ypsomed Holding AG | Eli Lilly and Co | Sanofi | Novo Nordisk AS | Becton Dickinson and Co |
|---|---|---|---|---|---|
| Headquarters | Switzerland | United States of America | France | Denmark | United States of America |
| City | Burgdorf | Indianapolis | Paris | Bagsvaerd | Franklin Lakes |
| State/Province | - | Indiana | Ile-de-France | - | New Jersey |
| No. of Employees | 2,099 | 50,000 | 76,493 | 68,794 | 72,000 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Gilbert Achermann | Chairman | Executive Board | 2022 | 62 |
| Paul Fonteyne | Vice Chairman | Executive Board | 2020 | 65 |
| Simon Michel | Director; Chief Executive Officer | Executive Board | 2014 | 49 |
| Samuel Kunzli | Chief Financial Officer | Senior Management | 2024 | 42 |
| Frank Mengis | Chief Operating Officer | Senior Management | 2015 | 62 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer